Product Information

BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET is a generic product labeled by American Health Packaging, priced at $0.7351 per EA under NDC 60687063765. Its NADAC has been published 242 times since Apr 6, 2022.

FDA first approved this application on Mar 30, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET

Buprenorphine and Naloxone
$0.7351per EA
DEA Schedule CIII

Strength

8; 2 mg/1; mg/1

NDC

60687063765

Classification

Generic

Dosage Form

TABLET

Route

SUBLINGUAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205601

FDA Approved

3/30/2020

TE Code

AB

On Market Since

3/14/2022

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists
Partial Opioid Agonist
Partial Opioid Agonists

Price Statistics

The NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has been published 242 times since Apr 6, 2022, and over the history we have for it it has declined 32.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7351 per EA
All-time high$1.1327 (Oct 12, 2022)
All-time low$0.6322 (Jul 22, 2026)
52-week high$0.7351
52-week low$0.6322
Median price$0.8587
Average price$0.8550
Largest weekly change+29.6% (Aug 21, 2024)
Weeks tracked242
Tracking sinceApr 6, 2022

Price History

1W

+2.5%

1M

+10.9%

3M

+15.2%

6M

+8.4%

1Y

+4.6%

3Y

-20.9%

5Y

N/A

All

-32.3%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET, manufactured by American Health Packaging, is $0.7351 per EA (NDC 60687063765), effective Nov 18, 2026.

How has the price of BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET changed over time?

Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has declined 32.3%. It has been tracked across 242 weekly CMS publications since Apr 6, 2022.

What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?

Since Apr 6, 2022, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has ranged from a low of $0.6322 (Jul 22, 2026) to a high of $1.1327 (Oct 12, 2022), with a median of $0.8587 per EA.

Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?

BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET (NDC 60687063765) is labeled by American Health Packaging, and CMS classifies it as a generic product.